Duey Marc - Insider Non-Derivative Transactions at Aprea Therapeutics, Inc. (APRE) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Dec 10, 2025, Duey Marc's relationship to Aprea Therapeutics, Inc. (APRE) is Director, and currently has 256,155 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other APRE insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Duey Marc - Insider Non-Derivative Transactions of APRE Common Stock
Duey Marc - Insider Non-Derivative Transactions at APRE
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 11, 2025 | P -- (Common Stock) | 21459 | 1.17 | 256155 |
| Jun 6, 2025 | Acquisition -- (Common Stock) | 1045 | 0 | 234696 |
| Oct 19, 2024 | Sell -- (Common Stock) | 6462 | 4.58 | 233651 |
| Oct 17, 2024 | P -- (Common Stock) | 30000 | 4.39 | 240113 |
| Oct 15, 2024 | P -- (Common Stock) | 190 | 2.58 | 210113 |
| Jun 21, 2024 | Acquisition -- (Common Stock) | 1045 | 0 | 209923 |
| Aug 24, 2023 | Acquisition -- (Common Stock) | 500 | 0 | 208878 |
| Aug 24, 2022 | C -- (Common Stock) | 11610 | 0 | 602 |
| Aug 24, 2022 | C -- (Common Stock) | 4009690 | 0 | 4167589 |